A Multicenter, Randomised, Double-Blind, Phase 3 Study Of Sunitinib In Metastatic Colorectal Cancer Patients Receiving Irinotecan, 5-Fluorouracil And Leucovorin (FOLFIRI) As First Line Treatment.
Phase of Trial: Phase III
Latest Information Update: 26 Feb 2017
At a glance
- Drugs Sunitinib (Primary) ; Fluorouracil; Folinic acid; Irinotecan
- Indications Colorectal cancer
- Focus Adverse reactions; Pharmacogenomic; Registrational; Therapeutic Use
- Acronyms SUN
- Sponsors Pfizer
- 03 Apr 2011 Pharmacogenomic results presented at the 102nd Annual Meeting of the American Association for Cancer Research.
- 19 Jan 2011 Additional lead trial centre, investigator identified as reported by Clinical Trials Registry - India.
- 19 Jan 2011 New source identified and integrated Clinical Trials Registry - India
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History